Bastei Lubbe on Track With Improved Profitability in the Second Quarter of 2026/2027

Bastei Lübbe reported first-half 2026/2027 revenue of EUR 55.2 million, slightly below the prior year, with EBIT of EUR 3.7 million and net profit of EUR 2.4 million versus EUR 3.9 million a year earlier. It lowered full-year revenue guidance to EUR 114–118 million from EUR 118–122 million and EBIT guidance to EUR 9–11 million from EUR 10–12 million, citing a weak book market, absent prior-year blockbuster titles and consumer restraint. Q2 EBIT margin improved to 8.4% from 4.4% in the previous quarter, while management expects stable or higher EBIT despite lower revenue.

Analysis

Earnings quality and second-order effects. The key issue is not the modestly lower sales outlook but the back-end burden embedded in it: after €3.7m of H1 EBIT, the revised full-year range requires €5.3–7.3m in H2. That makes stepped-up cost actions and title-level sell-through—not the sequential Q2 margin improvement—the test of whether earnings are becoming less hit-dependent. The implied margin improvement at the midpoint is plausible, but execution is concentrated in the remaining half-year. Rising author advances also increase exposure to title performance and working-capital timing.

Structural read-through. New Adult consolidation could reduce competitive intensity over time, but the modest declines in community and digital revenue mix do not yet demonstrate that these channels are offsetting a soft physical-book market. A new imprint expands the addressable catalogue, but near-term economics depend on successful launches and repeat readership; book-fair sell-outs alone do not establish durable demand. The immediate risk is renewed estimate pressure if holiday-season titles disappoint; over 6–18 months, a more diversified slate and sustained cost savings could lower earnings volatility.

Contrarian view. The market may focus on cost-led margin expansion and overlook how much H2 delivery is needed. Conversely, the guidance reduction is not proof of structural deterioration: if savings are recurring and the pipeline converts, earnings could improve despite flat-to-lower sales. Valuation and liquidity data are absent, so do not infer mispricing or a price target.

Key Decisions for Investors

• Avoid chasing a relief rally in BST on the sequential margin improvement alone. Treat the revised outlook as execution-dependent; there is no valuation or liquidity evidence here to justify an unconditional short.
• For the next results update, track H2 EBIT delivery against the €5.3–7.3m implied requirement, cost savings versus plan, and sell-through of key releases. Missed EBIT or another guidance cut would falsify the margin-recovery thesis and support reducing exposure.
• Watch author advances and inventory/working-capital disclosures alongside title performance: rising investment without repeatable sales would weaken the quality of reported earnings.
• Revisit a constructive BST stance only if subsequent reporting confirms durable cost reductions and stabilizing digital/community mix; if those metrics improve while revenues remain soft, the market may be underestimating the earnings resilience.